The Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS usually deploy funds on a monthly basis, with numerous deployments expected between now and the 5th April 2022.   

Please note that deployment in the 2021/22 tax year is subject to the closing date of 29th March 2022 for receipt of fully completed applications and cleared funds.  

For any client considering utilising carry back for the 2020/21 tax year, deployment prior to 5th April 2022 is essential.    

This highlights the potential advantage, especially at this time of the year, of recommending a provider which usually deploys funds on a monthly basis.  

Why invest? 

• Strong track record of proactively supporting and growing highly-innovative technology and life sciences companies; 

• Invest in 'knowledge intensive' companies, in line with EIS rules; 

• Quick deployment, with funds usually fully deployed on a monthly basis; 

• Access to a diverse portfolio of companies, at varying stages of commercialisation; 

• Sector experts; our team is made up of individuals engrained in the tech and life sciences sector; 

• Manager fee-free, at the point of investment for advised investors; ensuring up to 100% of any investment is potentially eligible for EIS tax reliefs and up to 100% of any investment is 'in the market.' 

Deepbridge takes an active role to guide, mentor and counsel the investee management team. The provision of hands-on operational experience combined with financial expertise can materially mitigate the investment risk borne by the Investor, along with comprehensive due diligence on Investee Companies. 

If you wish to discuss any of our investment propositions, please email the Deepbridge team on enquiries@deepbridgecapital.com or call 01244 746000.